tagging recent news
Kane Biotech Announces Grant of Options and Updates Investor Relations Agreement
WINNIPEG, MANITOBA -- (Marketwire) -- 07/09/12 -- Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, announces that the Company has granted an aggregate of 1,032,500 stock options at an exercise price of $.15 per common share to the management and employees of the Company. The options are set to expire five years from the date of grant and are subject to TSX Venture Exchange acceptance and the terms of Kane Biotech's stock option plan. In accordance with securities regulatory r [...]
